What is new in kidney cancer?

Expert Review of Anticancer Therapy

Volumn 9, Issue 12, 2009, Pages 1753-1755

  Kirkali, Ziya ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Metastatic; Renal cell carcinoma; Tyrosine kinase inhibitor

Indexed keywords

1 [4 (3 AMINO 1H INDAZOL 4 YL)PHENYL] 3 (2 FLUORO 5 METHYLPHENYL)UREA; AMG 102; BAY 73 4506; BEVACIZUMAB; CEDIRANIB; IMC 1121B; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; MONOCLONAL ANTIBODY; PAZOPANIB; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; REGORAFENIB; SORAFENIB; SUNITINIB; TEMSIROLIMUS; UNCLASSIFIED DRUG;

ANOREXIA; CLINICAL TRIAL; CONFERENCE PAPER; COUGHING; DIARRHEA; DISEASE FREE SURVIVAL; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERABILITY; DYSPNEA; EDEMA; FATIGUE; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MEDICAL SOCIETY; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RHINITIS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG DELIVERY SYSTEMS; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS;

EID: 73349126704     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.154     Document Type: Conference Paper

References (5)

1. Kirkali Z, Tuzel E. Systemic therapy of kidney cancer: tyrosine kinase inhibitors, angiogenesis or IL-2? Future Oncol. 5, 871-888 (2009).
2. Sternberg CN, Szczylik C, Lee E et al. A randomized, double-blind Phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC). J. Clin. Oncol. 27(Suppl. 15), (2009) (Abstract 5021).
3. Singh H, Milner CS, Aquilar Hernandez MM et al. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Cell. Signal. 21(8),1346-1350 (2009).
4. Giubellino A, Linehan WM, Bottaro DP. Targeting the Met signaling pathway in renal cancer. Expert Rev. Anticancer Ther. 9(6), 785-793 (2009).
5. Kirkali Z. Will we be able to "cure" metastatic renal cell carcinoma like we cure testicular tumors? Eur. Urol. 54, 712-714(2008).